Bridge-Comer Pania E, Vickers Mark H, Morton-Jones Jacob, Spada Ana, Rong Jing, Reynolds Clare M
Liggins Institute, University of Auckland, Auckland, New Zealand.
School of Public Health, Physiotherapy and Sports Science, Conway Institute, Institute of Food and Health, Diabetes Complications Research Centre, University College Dublin, Belfield, Dublin, Ireland.
J Dev Orig Health Dis. 2022 Oct;13(5):642-649. doi: 10.1017/S2040174422000022. Epub 2022 Mar 24.
As rates of obesity, diabetes, and related comorbidities have increased, the consumption of artificial sweeteners (ASs) as sugar substitutes has also risen in popularity as they are perceived as a healthier alternative to sugar sweetened products. However, there is conflicting evidence regarding the impact of AS intake on metabolic and reproductive health. Glucose intolerance during pregnancy due to intake of sugar sweetened foods can result in an increased risk for the development of type 2 diabetes post-pregnancy. However, limited information exists on the impact of AS intake during pregnancy and lactation on the mother's health in later life. We hypothesised both AS and fructose would impair metabolic health post-partum (PP) following maternal consumption during pregnancy and lactation. Female C57Bl/6 mice received a standard control diet ad libitum with either water (CD), fructose (Fr; 34.7 mm intake), or AS (AS;12.5 mm Acesulfame-K) throughout pregnancy and lactation. Post-weaning, AS and Fr dams were fed the CD diet for the remainder of the experiment. Oral glucose tolerance tests were undertaken 8 weeks PP and dams were humanely killed at 9 weeks PP, with adipose tissue and ovaries collected for analysis. Experimental diets did not influence maternal bodyweight. At 8 weeks PP, increased glucose intolerance was evident in both AS and Fr dams. Adipocyte size was significantly increased in both the AS and Fr groups PP. Further, in the ovary, AS increased expression of genes associated with follicular development and ovulation. Therefore, ASs may not represent beneficial substitutes to fructose during pregnancy, with the potential to increase the risk of T2DM in later life in mothers.
随着肥胖、糖尿病及相关合并症的发病率上升,作为糖替代品的人工甜味剂(ASs)的消费量也日益增加,因为人们认为它们是含糖产品更健康的替代品。然而,关于AS摄入量对代谢和生殖健康的影响,证据存在矛盾。孕期摄入含糖食物导致的葡萄糖不耐受会增加产后患2型糖尿病的风险。然而,关于孕期和哺乳期摄入AS对母亲晚年健康的影响,现有信息有限。我们假设,孕期和哺乳期母体摄入AS和果糖后,二者都会损害产后(PP)的代谢健康。雌性C57Bl/6小鼠在整个孕期和哺乳期随意进食标准对照饮食,同时饮用普通水(CD)、果糖(Fr;摄入量34.7 mmol)或AS(AS;12.5 mmol乙酰磺胺酸钾)。断奶后,AS组和Fr组的母鼠在实验剩余时间喂食CD饮食。产后8周进行口服葡萄糖耐量试验,产后9周对母鼠实施安乐死,收集脂肪组织和卵巢进行分析。实验饮食不影响母体体重。产后8周,AS组和Fr组的母鼠均明显出现葡萄糖不耐受增加。产后,AS组和Fr组的脂肪细胞大小均显著增加。此外,在卵巢中,AS增加了与卵泡发育和排卵相关基因的表达。因此,孕期AS可能并非果糖的有益替代品,有可能增加母亲晚年患2型糖尿病的风险。